The CBRA is a knowledge center for burden of disease and risk assessment methodology. It applies these methods to study the health and economic impact of public and animal health threats.


04 September 2016 | Dermoscopy cost-effectiveness
A new study published in European Journal of Cancer demonstrates how a previously developed melanoma disease model can be used in cost-effectiveness analyses in the melanoma detection field. The model and the methodology suggested in this new paper were applied to two cohorts of Belgian melanoma patients. Their analysis concluded that adequate dermoscopy training is cost-effective.

Read more in our publications section.